The DOI matches its Crossref record.
Risk factors for serious infection during treatment with cyclophosphamide and high‐dose corticosteroids for systemic lupus erythematosus
Abstract
Objective. To determine risk factors for serious infection during treatment with cyclophosphamide (CYC) and high‐dose corticosteroids in systemic lupus erythematosus (SLE). Methods. Records of 100 SLE patients who had received CYC were examined for documentation of serious infections that occurred during CYC therapy and the subsequent 3 months. Results. Infection occurred in 45 of 100 patients during CYC therapy. Patients with infection were more likely to have multiple organ disease (49% versus 29%; P = 0.04), a lower nadir in the white blood cell (WBC) count (2,818 versus 3,558 cells/μl; P = 0.02), and a higher maximum corticosteroid dose (195 versus 73 mg; P ≤ 0.01) than patients without infection. Infection occurred with equal prevalence in those who received intravenous (IV) (39%) or oral (40%) CYC, but was more common with use of sequential IV and oral therapy (68%). By multivariate analysis, the strongest association with infection was a WBC nadir ≤3,000 cells/μl (odds ratio [OR] 2.8, 95% confidence interval [95% CI] 1.4–5.5) and use of sequential IV and oral CYC (OR 2.3, 95% CI 1.2–4.3). Infection occurred in more CYC‐treated patients taking concomitant steroids than in those treated with high‐dose steroids alone (45% versus 12%; P = 0.001). Fatal and opportunistic infections during CYC therapy were associated with a low WBC nadir and a high maximum corticosteroid dose. Conclusion. The risk of serious infection in patients with SLE is influenced by the inclusion of CYC in the treatment regimen. The likelihood of infection in this setting is enhanced by CYC‐induced reductions in the total WBC count <3,000 cells/μl and by sequential IV and oral therapy. Both of these factors may be indicators of aggressive cytotoxic treatment, underscoring the need for close observation during treatment to minimize the risk of serious infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Predictors of major infections in systemic lupus erythematosus
Ruiz-Irastorza, G., Olivares, N., Ruiz-Arruza, I., Martinez-Berriotxoa, A., Egurbide, M.-V., & Aguirre, C. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2764 · Cited by 374
Danza, A., & Ruiz-Irastorza, G. (2013) · Lupus · doi:10.1177/0961203313493032 · Cited by 359
Mortality and causes of death in systemic lupus erythematosus
Trager, J., & Ward, M. M. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200109000-00002 · Cited by 264
Infectious complications in SLE after immunosuppressive therapies
Kang, I., & Park, S. H. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200309000-00002 · Cited by 255
Metadata
- Authors
- Pryor, B. D., Bologna, S. G., & Kahl, L. E.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1996-09
- Volume
- 39
- Issue
- 9
- Pages
- 1475-1482
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2100317664
- Cited by
- 236
- References
- 0
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk factors for serious infection during treatment with cyclophosphamide and high‐dose corticosteroids for systemic lupus erythematosus. https://app.cochat.ai/papers/10.1002/art.1780390906
- The paper
- Pryor, B. D., Bologna, S. G., & Kahl, L. E. (1996). Risk factors for serious infection during treatment with cyclophosphamide and high‐dose corticosteroids for systemic lupus erythematosus. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780390906
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.